POSTER SESSION VI Wednesday, March 02, 2005   —  1:00 - 4:00 PM Convention Center, Exhibit Hall B HEMATOPATHOLOGY 177 NPM-ALK Modifies Cytoskeleton and Cellular Shape by the Activation of Rac1, CDC42 and p130Cas (102) C Ambrogio, A Manazza, L Riera, L Barberis, C Costa, G Palestro, G Inghirami, R Chiarle - University of Turin, Turin, Italy; New York University, New York, NY 178 Differential Expression of Cyclin D3 in ALK+ and ALK- Anaplastic Large Cell Lymphoma (ALCL) (1056) R Dalton, MP Oyarzo, C Atwell, S Wang, GZ Rassidakis, LJ Medeiros - The University of Texas MD Anderson Cancer Center, Houston, TX 179 CD30 Expression in Anaplastic Large Cell Lymphomas Is Dependent on ALK Tyrosine Kinase Activity Via Stat3 Phosphorylation and JunB Upregulation (1041) F Boccalatte, R Piva, A Manazza, G Palestro, R Chiarle, G Inghirami - University of Turin, Turin, Italy; New York University School of Medicine, New York, NY 180 Comparison of Analysis Methods for Identification of T-Cell Clonality Using PCR with Capillary Electrophoresis (1057) A Djalilvand, CE Hill, KP Mann - Emory University School of Medicine, Atlanta, GA 181 Subset of Mature (Peripheral) CD8+ T-Cell Lymphoproliferations Co-Express CD117 (1073) W Gorczyca, P-S Lee, HY Dong, CD Wu - Genzyme Genetics, New York, NY 182 Angioimmunoblastic T-Cell Lymphoma: Histological Progression Is Associated with EBV and HHV6 Infection (1203) Y Zhou, AD Attygalle, SS Chuang, T Diss, A Dogan, MQ Du - Univeristy of Cambridge, Cambridge, United Kingdom; University College London, London, United Kingdom; Chi-Mei Medical Center, Tainan, Taiwan 183 Spectrum of Bone Marrow Findings in Patients with Angioimmunoblastic T-Cell Lymphoma (1078) KL Grogg, WG Morice, WR Macon - Mayo Clinic, Rochester, MN 184 Flow Cytometric Evaluation of Coexpression of CD5 and CD10 in Lymph Nodes and Lymphoid Tumors (1142) JM Polski - University of South Alabama, Mobile, AL 185 Cellular FLIP L-Mediated Resistance to Fas-Induced Apoptosis in NK/T-Cell Lymphomas (1094) YK Jeon, H Kim, YA Kim, YN Kim, CW Kim - Cancer Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea; Seoul City Boramae Hospital, Seoul, Republic of Korea 186 Low Levels of Herpesvirus Reactivation Are Detected in Mycosis Fungoides Lesions (1104) S Konoplev, M Oyarzo, K Patel, LJ Medeiros, M Duvic, D Jones - UT MD Anderson Cancer Center, Houston, TX 187 An Increased kappa-to-lambda Light Chain Ratio by Flow Cytometry in Germinal Center B-Cells in Hashimoto's Thyroiditis May Not Always Be Diagnostic of Lymphoma (1044) HI Chen, I Akpolat, A Ewton, MR Schwartz, D Mody, CC Chang - Baylor College of Medicine, Houston, TX; The Methodist Hospital, Houston, TX 188 Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease): Lesional Cells Exhibit an Immature Dendritic Cell Phenotype and Produce Interferon (1140) ME Pilichowska, JL Pinkus, GS Pinkus - Brigham and Women's Hospital; Harvard Medical School, Boston, MA 189 Bone Marrow Pathology in Human Herpes Virus 8 (HHV8) - Associated Multicentric Castleman Disease (1033) CM Bacon, RF Miller, M Noursadeghi, C McNamara, MQ Du, A Dogan - UCL Hospitals, London, United Kingdom; Royal Free Hospital, London, United Kingdom; University of Cambridge, United Kingdom 190 Expression of Intracellular Molecules Involved in BCR Signaling in Primary Effusion Lymphoma (PEL) Cell Lines (1088) E Hyjek, D DiBartolo, A Chadburn, A Chiu, DM Knowles, E Cesarman - Weill Medical College of Cornell University, New York, NY 191 t(14;18)(q32;21) Involving IGH and MALT1 Is Uncommon in Cutaneous MALT Lymphomas and Primary Cutaneous Diffuse Large B-Cell Lymphomas (1188) NT Wongchaowart, BK Kim, ED Hsi, SH Swerdlow, RR Tubbs, JR Cook - Cleveland Clinic Foundation, Cleveland, OH; University of Pittsburgh School of Medicine, Pittsburgh, PA 192 Secondary Cytogenetic Aberrations Characteristic of Marginal Zone Lymphoma in Follicular Lymphoma with t(14;18)(q32;q21) and Their Association with Marginal Zone Morphologic Phenotype (1176) E Torlakovic, H Aamot, S Heim - Royal University Hospital, Saskatoon, SK, Canada; The Norwegian Radium Hospital, Oslo, Norway 193 Extranodal Marginal Zone Lymphoma (EMZL) Involving the Peripheral Blood: A Report of 4 Cases (1139) A Pildain, RW McKenna, SH Kroft - UT Southwestern, Dallas, TX 194 Outcome and Prognostic Factors in Ocular Adnexal Lymphoma (113) M Nola, A Lukenda, M Kalauz, M Petrovecki, M Sicaja, Z Prka, M Tojagic, N Stiglmayer - Zagreb University School of Medicine, Zagreb, Croatia; Zagreb Clinical Hospital Center, Zagreb, Croatia 195 Utility of Skp-2 and MIB-1 in Grading Follicular Lymphomas Using Quantitative Image Analysis (1202) K Zhang, JW Prichard, F Lin - Geisinger Medical Center, Danville, PA 196 Aberrant Antigenic Expression in Follicular Lymphoma - A Flow Cytometric Study (1152) S Ray, FE Craig, SH Swerdlow - University of Pittsburgh School of Medicine, Pittsburgh, PA 197 CD30 Expression in Follicular Lymphoma- Correlation with Grade and Disease Progression (1169) M Sur, L Elavathil, C Ross - McMaster University, Hamilton, ON, Canada 198 The Transactivating Isoforms of p63 Are Overexpressed in Grade 3 Follicular Lymphomas (FL) Irrespective of the Occurrence of Gene Abnormalities (1145) G Pruneri, S Fabris, MO Biasi, S Valentini, P Dell'Orto, R Fasani, L Cattaneo, B Del Curto, A Neri, G Viale - European Institute of Oncology and University of Milan, Milan, Italy; Ospedale Maggiore, Milan, Italy 199 Follicular Lymphoma of the Thyroid Gland (1034) CM Bacon, T Diss, H Ye, MQ Du, RD Gascoyne, A Dogan, PG Isaacson - UCL Hospitals, London, United Kingdom; University of Cambridge, United Kingdom; University of British Columbia; British Columbia Cancer Agency, Vancouver, Canada 200 p21 Associated Kinase-1 Is a Poor Prognostic Marker in Diffuse Large B-Cell Lymphomas (1100) F Khanani, S H. Khayyata, M Kurrer, J Frank, E Levi - Harper Hospital, Detroit, MI; University Hospital, Zurich, Switzerland; John D. Dingell VAMC, Wayne State University, Detroit, MI 201 BCL-6 Expression but Not Caspase-3 Expression Correlates with Survival in Unselected Patients with Diffuse Large B-Cell Lymphoma (1108) MO Kurrer, D Korol, H Ohgaki, E Levi - University Hospital, Zurich, Switzerland; International Agency for Research on Cancer, Lyon, France; Wayne State University Medical School, Detroit, MI 202 This poster has been withdrawn -   203 Comparison of Two Commercially Available MUM-1 Antibodies for Immunohistochemical (IHC) Classification of Diffuse Large B-Cell Lymphoma (DLBCL) into Germinal Center B-Cell and Non-Germinal Center B-Cell Subtypes as Compared to Gene Expression Profile (GEP) and Patient Survival (1079) CF Haarer, RA Roberts, YM Frutiger, TM Grogan, LM Rimsza - University of Arizona, Tucson, AZ 204 Cell-of-Origin Is an Important Biomarker in Diffuse Large B-Cell Lymphoma (DLBCL) (1065) P Farinha, G Bebb, R Siebert, D Horsman, JM Connors, RD Gascoyne - British Columbia Cancer Agency, Vancouver, BC, Canada; Institute of Human Genetics, Kiel, Germany 205 Germinal Center and Activated B-Cell Profiles Separate Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma in AIDS and Non-AIDS Cases (1075) R Gormley, R Madan, A Dulau, D Xu, E Tamas, PK Bhattacharya, A LeValley, X Xue, P Kumar, J Sparano, KH Ramesh, V Pulijaal, L Cannizzaro, D Walsh, HL Ioachim, H Ratech - Montefiore Med Ctr/Albert Einstein Coll Med, Bronx, NY; Lenox Hill Hospital, New York, NY 206 Lymphoid Neoplasms Associated with Concurrent t(14;18) and c-myc Translocations Have a Poor Prognosis (1097) A Kanungo, LJ Medeiros, A Glassman, P Lin - MD Anderson Cancer Center, Houston, TX 207 The Utility of CD71 Expression by Flow Cytometry in Differentiating Indolent from Aggressive CD10-Positive B Cell Lymphomas (1189) JM Wu, MJ Borowitz, EG Weir - The Johns Hopkins Hospital, Baltimore, MD 208 Malignant Lymphomas of the Retroperitoneum (1076) MR Grant, B Schnitzer, R Valdez, WG Finn - University of Michigan Hospitals and Health Centers, Ann Arbor, MI